Latest Chemed Inc (CHE) Headlines Insider Tradi
Post# of 37
Posted On: 03/13/2014 9:51:27 PM
Latest Chemed Inc (CHE) Headlines
Insider Trading Alert - SPLK, CHE And F Traded By Insiders
at The Street - Thu Mar 13, 10:00AM CDT
Stocks with insider trader activity include SPLK, CHE and F
Almost Family (AFAM) in Focus: Stock Tumbles 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:40AM CDT
Shares of Almost Family fell nearly 10% last session and also witnessed continuous downtrend in the past one-month time frame over 14%. So its time to keep a close watch on this firm in the near future and especially on earnings estimates following the recent slump.
Quest Diagnostics to Buy Summit Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 4:00PM CDT
Post acquisition, Summit Health's services will complement the health and wellness business of Quest Diagnostics.
Gentiva Ratings Outlook Slashed on Weak Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 3:40PM CDT
Moody's Investors service has recently downgraded the rating outlook on Gentiva Health Services to negative from stable.
12.1% Return Seen to Date on SmarTrend Chemed Call (CHE)
Comtex SmarTrend(R) - Mon Mar 10, 11:20AM CDT
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on November 18th, 2013 at $76.13. In approximately 4 months, Chemed has returned 12.12% as of today's recent price of $85.35.
Tenet, Yale New Haven Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:30PM CST
Tenet Healthcare Corporation is set to establish its foothold in Connecticut through its latest partnership with Yale New Haven Health System
Weakness Seen in Gentiva Health Services (GTIV) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:35AM CST
Gentiva has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Tenet Prices Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 12:20PM CST
Tenet Healthcare Corporation has recently announced that it is issuing 5-year senior unsecured notes worth $600 million
Cherkizovo Group OJSC: 2013 Financial Results
Marketwire - Thu Mar 06, 2:40AM CST
SOURCE: OJSC Cherkizovo Group
HCA to Issue Senior Notes, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 3:58PM CST
Shares of HCA Holdings, Inc. moved down 1.2% to $51.06 on Mar 4, 2014 after the company decided to issue senior secured notes worth $3 billion.
Chemed Corporation to Present at the Barclays Capital 2014 Global Healthcare Conference
Business Wire - Wed Mar 05, 11:42AM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Barclays Capital 2014 Global Healthcare Conference on Wednesday, March 12, 2014, at approximately 2:30 p.m. (ET) at the Loews Miami Beach Hotel in Miami, Florida.
Gentiva (GTIV) in Focus: Stock Tumbles 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:36AM CST
The shares of Gentiva fell over 10% on the day. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $10.3 to $11.1 in the past one-month time frame. This home health services provider company has seen a flat track record when it comes to current year estimate revisions.
Insider Trading Alert - CSOD, CHE And ABG Traded By Insiders
at The Street - Tue Mar 04, 10:15AM CST
Stocks with insider trader activity include CSOD, CHE and ABG
Humana's Ratings Affirmed by A.M. Best - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 5:40PM CST
Credit rating agency A. M. Best Co. has affirmed some ratings of Humana Inc.
Shares of CHE Up 11.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 27, 5:23PM CST
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on November 18th, 2013 at $76.13. In approximately 3 months, Chemed has returned 11.66% as of today's recent price of $85.00.
Tenet Arm, University Health Pen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 3:55PM CST
Tenet Healthcare subsidiary Conifer Health Solutions has inked a deal with University Health System.
DCP Midstream Partners Announces Public Offering of Common Units
Thomson Reuters ONE - Wed Feb 26, 3:20PM CST
DCP MIDSTREAM PARTNERS ANNOUNCES PUBLIC OFFERING OF COMMON UNITS
ArcelorMittal completes acquisition of ThyssenKrupp Steel USA
Thomson Reuters ONE - Wed Feb 26, 3:10PM CST
Luxembourg, 26 February 2014
3 Stocks With Upcoming Ex-Dividend Dates: THI, CHE, HSH
at The Street - Wed Feb 26, 9:01AM CST
THI CHE HSH are going ex-dividend tomorrow, Thursday, Feb. 27, 2014, 5:00 AM ET
Chemed Corp. (CHE) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:45AM CST
Chemed Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
Insider Trading Alert - SPLK, CHE And F Traded By Insiders
at The Street - Thu Mar 13, 10:00AM CDT
Stocks with insider trader activity include SPLK, CHE and F
Almost Family (AFAM) in Focus: Stock Tumbles 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:40AM CDT
Shares of Almost Family fell nearly 10% last session and also witnessed continuous downtrend in the past one-month time frame over 14%. So its time to keep a close watch on this firm in the near future and especially on earnings estimates following the recent slump.
Quest Diagnostics to Buy Summit Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 4:00PM CDT
Post acquisition, Summit Health's services will complement the health and wellness business of Quest Diagnostics.
Gentiva Ratings Outlook Slashed on Weak Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 3:40PM CDT
Moody's Investors service has recently downgraded the rating outlook on Gentiva Health Services to negative from stable.
12.1% Return Seen to Date on SmarTrend Chemed Call (CHE)
Comtex SmarTrend(R) - Mon Mar 10, 11:20AM CDT
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on November 18th, 2013 at $76.13. In approximately 4 months, Chemed has returned 12.12% as of today's recent price of $85.35.
Tenet, Yale New Haven Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:30PM CST
Tenet Healthcare Corporation is set to establish its foothold in Connecticut through its latest partnership with Yale New Haven Health System
Weakness Seen in Gentiva Health Services (GTIV) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:35AM CST
Gentiva has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Tenet Prices Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 12:20PM CST
Tenet Healthcare Corporation has recently announced that it is issuing 5-year senior unsecured notes worth $600 million
Cherkizovo Group OJSC: 2013 Financial Results
Marketwire - Thu Mar 06, 2:40AM CST
SOURCE: OJSC Cherkizovo Group
HCA to Issue Senior Notes, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 3:58PM CST
Shares of HCA Holdings, Inc. moved down 1.2% to $51.06 on Mar 4, 2014 after the company decided to issue senior secured notes worth $3 billion.
Chemed Corporation to Present at the Barclays Capital 2014 Global Healthcare Conference
Business Wire - Wed Mar 05, 11:42AM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Barclays Capital 2014 Global Healthcare Conference on Wednesday, March 12, 2014, at approximately 2:30 p.m. (ET) at the Loews Miami Beach Hotel in Miami, Florida.
Gentiva (GTIV) in Focus: Stock Tumbles 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:36AM CST
The shares of Gentiva fell over 10% on the day. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $10.3 to $11.1 in the past one-month time frame. This home health services provider company has seen a flat track record when it comes to current year estimate revisions.
Insider Trading Alert - CSOD, CHE And ABG Traded By Insiders
at The Street - Tue Mar 04, 10:15AM CST
Stocks with insider trader activity include CSOD, CHE and ABG
Humana's Ratings Affirmed by A.M. Best - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 5:40PM CST
Credit rating agency A. M. Best Co. has affirmed some ratings of Humana Inc.
Shares of CHE Up 11.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 27, 5:23PM CST
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on November 18th, 2013 at $76.13. In approximately 3 months, Chemed has returned 11.66% as of today's recent price of $85.00.
Tenet Arm, University Health Pen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 3:55PM CST
Tenet Healthcare subsidiary Conifer Health Solutions has inked a deal with University Health System.
DCP Midstream Partners Announces Public Offering of Common Units
Thomson Reuters ONE - Wed Feb 26, 3:20PM CST
DCP MIDSTREAM PARTNERS ANNOUNCES PUBLIC OFFERING OF COMMON UNITS
ArcelorMittal completes acquisition of ThyssenKrupp Steel USA
Thomson Reuters ONE - Wed Feb 26, 3:10PM CST
Luxembourg, 26 February 2014
3 Stocks With Upcoming Ex-Dividend Dates: THI, CHE, HSH
at The Street - Wed Feb 26, 9:01AM CST
THI CHE HSH are going ex-dividend tomorrow, Thursday, Feb. 27, 2014, 5:00 AM ET
Chemed Corp. (CHE) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:45AM CST
Chemed Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
(0)
(0)Chemed Corp. (CHE) Stock Research Links
Scroll down for more posts ▼